Total Patients
0
📁 Saved in history
Today's Revenue
₹0
↑ Updated from billing
Active Queue
0
👤 Patients waiting
Appointments
0
📆 Today's schedule
⚡ Quick Actions
New Prescription
Start OPD visit
Lab Reports
Interpret results
Drug Search
1244+ drugs
Disease DB
430+ diseases
Clinical Scores
SOFA, GCS & more
Billing
Create invoice
Analytics
Charts & trends
Vitals
Track & monitor
🏥 Today's OPD Queue
🏥
No patients in queue.Click "+ Add" to add a patient.
⚡ Recent Activity
Welcome to K Spider Clinic Platform!
Complete your doctor profile to get started.
Complete your doctor profile to get started.
Now
Phase 4 Active — 430+ diseases, 1244+ drugs
Today
Multi-language support: 10 Indian languages
Active
📅 Today's Appointments
📅
No appointments scheduled today.Click "+ Schedule" to add one.
Advertisement — Google AdSense
📢 728×90 Leaderboard Ad Space
AI-GENERATED CONTENT: All suggestions, diagnoses, drug recommendations, interaction warnings, risk scores, and report interpretations are AI-generated using the K Spider AI system. These are for clinical reference only and must be independently verified by the prescribing doctor before any clinical decision or action.
FOR PHARMACISTS: Do NOT dispense any medicine based solely on this AI-generated document. Medicines must only be dispensed upon receipt of a valid, signed prescription from a registered medical practitioner as per Drugs & Cosmetics Act, 1940.
FOR DIAGNOSTIC LABS / INVESTIGATIONS: No investigation or test should be conducted solely on the basis of this AI output. All investigation orders must be confirmed and signed by the prescribing doctor before execution.
DOCTOR'S RESPONSIBILITY: The prescribing doctor bears full clinical and legal responsibility for all prescriptions issued. K Spider AI and K Spider for Kreation are not liable for any clinical decisions made on the basis of AI-generated content.
DATA PRIVACY: All patient data is stored locally on your device only. No patient data is transmitted to any external server. By using this tool, you confirm you are a registered medical practitioner and accept full clinical responsibility.
Advertisement — Google AdSense
📢 320×50 / 728×90 — Dashboard Ad Space | kspiderai.in
🕷️ K Spider AI – Doctor Elite Pro Max PHASE 2 PHASE 3
Phase 4: 265 Diseases · 18 Specialties · 998 Drugs · 282 Drug Combos · 10 Indian Languages Output · Emergency Alerts · Growth Charts · Risk Scoring — Professional AI clinical decision support. 100% Offline. HIPAA-compliant.
265
🗂️ Diseases (10 Specialties)
998
💊 Generic Drug Profiles
282
⚗️ Drug Combo Pairs
10
🌐 Output Languages
0
📄 Prescriptions Saved
46
⚠️ Interaction Pairs
100%
🔒 Offline / Local / HIPAA
PHASE 4
🚀 K Spider AI Version
🚨
Emergency Alert System
Auto-detects critical vitals and symptoms — triggers immediate visual emergency alerts with action guidance
⚗️
Drug Interaction Engine
46 critical interaction pairs with severity (Safe/Minor/Moderate/Severe/Contraindicated). Pregnancy & Elderly flags auto-applied
📏
Pediatric Growth Charts
WHO growth charts for height, weight, head circumference — auto-percentile classification with Z-scores
⚖️ CLINICAL RESPONSIBILITY DISCLAIMER — K Spider AI Phase 3
"This tool is a clinical assistance system. Final responsibility lies with the prescribing doctor. K Spider AI is not responsible for misuse."
This AI tool is designed to ASSIST registered medical practitioners ONLY. All AI-generated suggestions — diagnoses, drug recommendations, interaction warnings, risk scores, and report interpretations — must be independently verified by the prescribing doctor before clinical use. This is NOT a substitute for professional medical evaluation, examination, or judgment. Patient data is stored locally only — never transmitted. By using this tool, you confirm you are a registered medical practitioner and accept full clinical responsibility for all prescriptions issued. Emergency alerts are AI-generated and require immediate clinical reassessment — they are not a replacement for clinical triage protocols.
🚀 Phase 3 Activated: PHASE 4 Disease DB 430+ conditions (10 specialties) · Emergency Alert Engine · Drug Interaction Warning System · Pregnancy/Elderly Safety Flags · Pediatric Growth Chart Calculator · Enhanced BMI/BP · Auto Risk Scoring · Multi-language Output (EN/HI/GU/MR/TA/TE/BN) · AdSense + Affiliate Earning Spaces
❤️ Cardiac Markers
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| Troponin I (cTnI) | ng/mL | <0.04 (normal) | ||
| Troponin T (cTnT) | ng/mL | <0.01 (normal) | ||
| CK-MB (Creatine Kinase-MB) | ng/mL | <5.0 | ||
| Total CK (Creatine Kinase) | U/L | 30–200 (M) / 26–140 (F) | ||
| LDH (Lactate Dehydrogenase) | U/L | 120 – 246 | ||
| BNP (Brain Natriuretic Peptide) | pg/mL | <100 (normal); 100–400 (borderline) | ||
| NT-proBNP | pg/mL | <125 (age <75); <450 (age ≥75) | ||
| D-Dimer | mg/L FEU | <0.5 (rules out DVT/PE) | ||
| Myoglobin | ng/mL | 17–106 (M) / 14–58 (F) | ||
| hs-CRP (High Sensitivity) | mg/L | <1.0 (low risk); 1–3 (avg); >3 (high CV risk) | ||
| Homocysteine | μmol/L | 5 – 15 | ||
| Lipoprotein (a) [Lp(a)] | mg/dL | <30 (optimal) |
🩸 Coagulation Profile (PT / INR / aPTT)
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| PT (Prothrombin Time) | seconds | 11 – 13.5 | ||
| INR (International Normalized Ratio) | ratio | 0.8 – 1.2 (therapeutic 2.0–3.0 on Warfarin) | ||
| aPTT (Activated Partial Thromboplastin Time) | seconds | 25 – 35 | ||
| TT (Thrombin Time) | seconds | 14 – 19 | ||
| Fibrinogen | mg/dL | 200 – 400 | ||
| D-Dimer | mg/L FEU | <0.5 | ||
| Bleeding Time (BT) | minutes | 1 – 7 | ||
| Clotting Time (CT) | minutes | 4 – 8 | ||
| Factor VIII Activity | % | 50 – 150 | ||
| Antithrombin III (AT-III) | % | 80 – 120 |
🧪 Urine Routine & Microscopy (R/M)
Enter numeric values where applicable. For qualitative tests (Color, Clarity etc.) use text fields.
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| pH | — | 4.5 – 8.0 | ||
| Specific Gravity | — | 1.003 – 1.030 | ||
| Protein (Albumin) | mg/dL | <30 (trace acceptable) | ||
| Glucose (Sugar) | mg/dL | <0 (absent) | ||
| Ketones | mg/dL | Absent (0) | ||
| Bilirubin (Urine) | mg/dL | Absent / Negative | ||
| Urobilinogen | mg/dL | 0.1 – 1.0 (Ehrlich Units) | ||
| Nitrites | — | Absent (0=neg; 1=pos) | ||
| RBC (Microscopy) | /HPF | 0 – 3 | ||
| WBC/Pus Cells (Microscopy) | /HPF | 0 – 5 | ||
| Epithelial Cells | /HPF | 0 – 5 (Squamous) | ||
| Casts (Hyaline) | /LPF | 0 – 2 (occasional normal) | ||
| Crystals (Oxalate etc.) | /HPF | 0 – few (trace) | ||
| Microalbumin (24h) | mg/day | <30 (normal); 30–300 (microalbuminuria) | ||
| Urine Creatinine | mg/dL | 20 – 320 | ||
| Urine Culture (Colony Count) | CFU/mL | <10,000 (negative); >100,000 = UTI |
💩 Stool / Fecal Analysis
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| RBC (Stool Microscopy) | /HPF | Absent (0) | ||
| WBC / Pus Cells | /HPF | 0 – 3 | ||
| Occult Blood (FOBT) | — | Negative (0=neg; 1=pos) | ||
| Ova / Parasites / Cysts | — | Absent (0=neg; 1=pos) | ||
| Fat Globules | — | Absent (0=neg; 1=pos) | ||
| Reducing Substances | — | Absent (0=neg; 1=pos) | ||
| Calprotectin (Fecal) | μg/g | <50 (normal); 50–200 (borderline) | ||
| H. pylori Antigen (Stool) | — | Negative (0=neg; 1=pos) | ||
| Stool Culture (Bacterial) | — | No growth (0=neg; 1=pos) |
🧬 Hormones & Reproductive Panel
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| FSH (Follicle Stimulating Hormone) | mIU/mL | 1.5–12.4 (M); 2.5–10.2 (F follicular); >25 (F menopause) | ||
| LH (Luteinizing Hormone) | mIU/mL | 1.7–8.6 (M); 1.0–11.4 (F follicular) | ||
| Estradiol (E2) | pg/mL | <29 (M); 30–400 (F follicular); <30 (F menopause) | ||
| Progesterone | ng/mL | <0.2 (M); 0.1–0.9 (F follicular); 6–25 (F luteal) | ||
| Testosterone (Total) | ng/dL | 270–1070 (M); 15–70 (F) | ||
| Prolactin (PRL) | ng/mL | 2.0–18 (M); 2.0–29.7 (F non-pregnant) | ||
| Cortisol (8 AM Serum) | μg/dL | 6.2–19.4 (AM); 1.4–8.0 (PM) | ||
| DHEA-S (Dehydroepiandrosterone Sulfate) | μg/dL | 110–510 (M 25–34); 65–380 (F 25–34) | ||
| AMH (Anti-Müllerian Hormone) | ng/mL | 1.0–3.5 (optimal fertility); <0.5 (poor reserve) | ||
| Insulin-like Growth Factor 1 (IGF-1) | ng/mL | 100–303 (adult); age-dependent | ||
| hCG (Beta-HCG) | mIU/mL | <5 (non-pregnant); varies in pregnancy | ||
| Parathyroid Hormone (PTH) | pg/mL | 15 – 65 |
🔬 Tumor / Cancer Markers
Important: Tumor markers are screening aids only. Elevated values must be correlated with clinical findings, imaging, and biopsy. Many non-cancer conditions also elevate these markers.
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| PSA (Prostate Specific Antigen) | ng/mL | <4.0 (<40 yrs: <2.5) | ||
| Free PSA | % | >25% (lower cancer risk); <10% (high risk) | ||
| CEA (Carcinoembryonic Antigen) | ng/mL | <2.5 (non-smoker); <5.0 (smoker) | ||
| CA-125 (Ovarian / Peritoneal) | U/mL | <35 | ||
| CA 19-9 (Pancreatic / GI) | U/mL | <37 | ||
| AFP (Alpha-Fetoprotein) | ng/mL | <10 (non-pregnant adult) | ||
| CA 15-3 (Breast Cancer) | U/mL | <31 | ||
| CA 72-4 (Gastric Cancer) | U/mL | <6.9 | ||
| CA 50 (GI / Lung) | U/mL | <25 | ||
| NSE (Neuron-Specific Enolase) | ng/mL | <17 (lung/neuroendocrine) | ||
| CYFRA 21-1 (Lung SCC) | ng/mL | <3.3 | ||
| Beta-2 Microglobulin | mg/L | 0.8 – 2.4 | ||
| LDH (Lymphoma marker) | U/L | 120 – 246 | ||
| Calcitonin (Thyroid MTC) | pg/mL | <11.5 (M); <4.6 (F) |
🦠 Infectious Disease Panel
Values: 0 = Negative / Non-reactive, 1 = Positive / Reactive. Use numeric titers where applicable.
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| HIV 1 & 2 (ELISA) | 0/1 | Non-reactive (0) | ||
| HBsAg (Hepatitis B Surface Antigen) | 0/1 | Negative (0) | ||
| Anti-HCV (Hepatitis C Antibody) | 0/1 | Non-reactive (0) | ||
| HBeAg (Hep B e-Antigen) | 0/1 | Negative (0) | ||
| Anti-HBs (Hepatitis B Antibody) | mIU/mL | >10 (immune); >100 (well immune) | ||
| VDRL / Syphilis (RPR) | 0/1 | Non-reactive (0) | ||
| Widal (S.typhi O — Titer) | Titer | <1:80 (endemic area: <1:160) | ||
| Widal (S.typhi H — Titer) | Titer | <1:80 (endemic area: <1:160) | ||
| Malaria (Peripheral Smear / RDT) | 0/1 | Negative (0) | ||
| Dengue NS1 Antigen | 0/1 | Negative (0) | ||
| Dengue IgM Antibody | 0/1 | Negative (0) | ||
| Dengue IgG Antibody | 0/1 | Negative (0) — past infection if pos | ||
| Chikungunya IgM | 0/1 | Negative (0) | ||
| Leptospira IgM | 0/1 | Negative (0) | ||
| Scrub Typhus IgM (Orientia) | 0/1 | Negative (0) | ||
| COVID-19 Ag RDT | 0/1 | Negative (0) | ||
| Toxoplasma IgM | 0/1 | Negative (0) | ||
| ASO Titer (Streptococcal) | IU/mL | <200 (adult); <400 (child) | ||
| Procalcitonin (PCT) | ng/mL | <0.1 (no infection); 0.1–0.5 (mild); >0.5 (bacterial sepsis) |
🌡️ Arterial Blood Gas (ABG) Analysis
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| pH (Arterial Blood) | — | 7.35 – 7.45 | ||
| PaO₂ (Partial Pressure O₂) | mmHg | 75 – 100 | ||
| PaCO₂ (Partial Pressure CO₂) | mmHg | 35 – 45 | ||
| HCO₃⁻ (Bicarbonate) | mEq/L | 22 – 26 | ||
| Base Excess (BE) | mEq/L | −2 to +2 | ||
| SaO₂ (Oxygen Saturation) | % | 94 – 100 | ||
| SpO₂ (Pulse Oximetry) | % | 95 – 100 | ||
| Lactate (Serum) | mmol/L | 0.5 – 2.0 (hyperlactatemia >2; sepsis >4) | ||
| Anion Gap | mEq/L | 8 – 16 (with albumin correction) | ||
| FiO₂ (Fraction of Inspired O₂) | % | 21% (room air) |
🛡️ Autoimmune & Immunology Panel
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| ANA (Antinuclear Antibody) | 0/1 (pos/neg) | Negative (0); >1:80 titer = significant | ||
| Anti-dsDNA (SLE marker) | IU/mL | <10 (negative); >200 = highly SLE-specific | ||
| RF (Rheumatoid Factor) | IU/mL | <14 (negative) | ||
| Anti-CCP (Anti-Cyclic Citrullinated Peptide) | U/mL | <17 (negative); >17 = Positive (RA-specific) | ||
| p-ANCA (MPO antibody) | 0/1 | Negative (0) | ||
| c-ANCA (PR3 antibody) | 0/1 | Negative (0) — Wegener's granulomatosis | ||
| Anti-Sm (Sm antigen — SLE) | 0/1 | Negative (0) — highly specific for SLE | ||
| Anti-SSA/Ro (Sjögren's) | 0/1 | Negative (0) | ||
| Anti-SSB/La (Sjögren's) | 0/1 | Negative (0) | ||
| Anti-Scl-70 (Scleroderma) | 0/1 | Negative (0) | ||
| Anti-Jo-1 (Myositis) | 0/1 | Negative (0) — antisynthetase syndrome | ||
| Complement C3 | mg/dL | 88 – 165 | ||
| Complement C4 | mg/dL | 16 – 47 | ||
| IgG (Immunoglobulin G) | mg/dL | 700 – 1600 | ||
| IgA (Immunoglobulin A) | mg/dL | 70 – 400 | ||
| IgM (Immunoglobulin M) | mg/dL | 40 – 230 | ||
| IgE Total (Allergy) | IU/mL | <100 (adult); <150 (allergic tendency) |
💧 Semen Analysis (WHO 2021 Criteria)
| Parameter | Your Value | Unit | Normal Range (WHO 2021) | Result |
|---|---|---|---|---|
| Ejaculate Volume | mL | ≥1.4 mL | ||
| Sperm Concentration | million/mL | ≥16 million/mL | ||
| Total Sperm Count | million/ejaculate | ≥39 million | ||
| Total Motility (PR + NP) | % | ≥42% | ||
| Progressive Motility (PR) | % | ≥30% | ||
| Normal Morphology (Kruger Strict) | % | ≥4% (normal forms) | ||
| Vitality (Live Sperm) | % | ≥54% | ||
| pH | — | 7.2 – 8.0 | ||
| Liquefaction Time | minutes | <60 minutes | ||
| WBC / Pus Cells (Semen) | million/mL | <1.0 (peroxidase +ve) | ||
| Agglutination | 0=absent | Absent (0) | ||
| Fructose (Seminal) | μmol/ejaculate | ≥13 μmol/ejaculate |
🧠 Cerebrospinal Fluid (CSF) Analysis
Clinical Context Required: CSF analysis must always be correlated with clinical presentation, imaging, and microbiological findings.
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| Opening Pressure | mmH₂O | 70 – 200 (lateral decubitus) | ||
| Total WBC (Cells) | cells/μL | 0 – 5 (adult); <30 (neonate) | ||
| RBC | cells/μL | 0 (absent in normal CSF) | ||
| Neutrophils % | % | <10% (bacterial meningitis: predominant neutrophils) | ||
| Lymphocytes % | % | 60–80% (viral/TB: lymphocytic predominance) | ||
| Protein (CSF) | mg/dL | 15 – 45 (lumbar); <25 (ventricular) | ||
| Glucose (CSF) | mg/dL | 45 – 80 (or 60–70% of serum glucose) | ||
| Serum Glucose (simultaneous) | mg/dL | (for CSF/Serum ratio calculation) | ||
| CSF Chloride | mEq/L | 120 – 130 | ||
| LDH (CSF) | U/L | <40 (10% of serum LDH) | ||
| Adenosine Deaminase / ADA (TB marker) | U/L | <10 (TB meningitis: typically >10) | ||
| India Ink Stain (Cryptococcus) | 0/1 | Negative (0) |
🦴 Bone Metabolism & Calcium Markers
| Parameter | Your Value | Unit | Normal Range | Result |
|---|---|---|---|---|
| Serum Calcium (Total) | mg/dL | 8.5 – 10.5 | ||
| Ionized Calcium | mg/dL | 4.5 – 5.3 (1.12–1.32 mmol/L) | ||
| Serum Phosphorus | mg/dL | 2.5 – 4.5 (adult) | ||
| Vitamin D (25-OH-D3) | ng/mL | >30 (sufficient); 20–30 (insufficient); <20 (deficient) | ||
| PTH (Parathyroid Hormone, intact) | pg/mL | 15 – 65 | ||
| ALP (Alkaline Phosphatase — Bone) | U/L | 40 – 130 (elevated in Paget's, osteomalacia) | ||
| Osteocalcin (BGP — bone formation) | ng/mL | 11–48 (M); 1–50 (F premenopause); 15–46 (F postmenopause) | ||
| CTX (C-Telopeptide — bone resorption) | ng/mL | <0.573 (M); <0.573 (F premenopause); <1.008 (F postmenopause) | ||
| Urine Calcium (24-hour) | mg/day | 100 – 300 (M); 100 – 250 (F) | ||
| DEXA T-Score (Lumbar/Hip) | SD units | >-1.0 (Normal); -1.0 to -2.5 (Osteopenia); <-2.5 (Osteoporosis) | ||
| Magnesium (Serum) | mg/dL | 1.7 – 2.4 |
🫁 Pulmonary Function Test (PFT / Spirometry)
Enter actual values. % Predicted = (Actual / Predicted) × 100. Enter % predicted if available.
| Parameter | Your Value (%Pred) | Unit | Normal Range | Result |
|---|---|---|---|---|
| FVC (Forced Vital Capacity) | % Predicted | ≥80% predicted | ||
| FEV1 (Forced Exp. Volume in 1 sec) | % Predicted | ≥80% predicted | ||
| FEV1/FVC Ratio | % | ≥70% (≥LLN) — <70% = Obstruction | ||
| FEF 25–75% (MMEF) | % Predicted | ≥65% predicted (small airway index) | ||
| PEF (Peak Expiratory Flow) | % Predicted | ≥80% predicted | ||
| TLC (Total Lung Capacity) | % Predicted | 80–120% predicted | ||
| RV (Residual Volume) | % Predicted | 80–120% predicted (>120% = air trapping) | ||
| DLCO (Diffusing Capacity CO) | % Predicted | ≥75% predicted | ||
| DLCO/VA (KCO — Transfer Coefficient) | % Predicted | ≥75% predicted | ||
| 6-Minute Walk Test (6MWT) | meters | >400m (adult); predicted: 400–700m by age/gender |
🍼 Pediatric Reference Panel
Pediatric normal ranges differ significantly by age. Enter child's age for context-specific interpretation.
| Parameter | Your Value | Unit | Note (Age-adjusted) | Result |
|---|---|---|---|---|
| Hemoglobin (Hb) | g/dL | 6mo–5yr: 11+; 5–12yr: 11.5+; >12yr: 12+ | ||
| Neonatal Bilirubin (Total) | mg/dL | Term: <12mg/dL physiologic; >15=phototherapy | ||
| WBC Count (Total) | K/μL | Newborn: 9–30; 1yr: 6–17; 4–7yr: 5–15 | ||
| Platelet Count | K/μL | 150 – 400 (similar to adults) | ||
| Blood Glucose (Fasting) | mg/dL | Neonate: 40–90; Child: 70–100 | ||
| Serum Calcium | mg/dL | Child: 8.8–10.8; Neonate: 7.0–12.0 | ||
| Serum Creatinine | mg/dL | Infant: 0.2–0.4; Child: 0.3–0.7; Adolescent: 0.5–1.0 | ||
| TSH (Pediatric) | mIU/L | Neonate: 0.5–6.0; Child: 0.4–5.0 | ||
| Lead Level (Children) | μg/dL | <3.5 (CDC 2021 reference value); >3.5 = investigate | ||
| CRP (Pediatric) | mg/L | <5 (normal); >40 = serious bacterial infection | ||
| Height (cm) — Z-Score Input | cm | ±2 SD of WHO growth chart for age/gender | ||
| Weight (kg) — Z-Score Input | kg | Assess for stunting/wasting per WHO Z-scores |
🌿 Allergy & IgE Panel
Total IgE is a general screening marker. Specific IgE (sIgE) tests indicate sensitization to individual allergens. Values in kUA/L: <0.35=Class 0 (none); 0.35–0.7=Class I; 0.7–3.5=Class II; 3.5–17.5=Class III; 17.5–50=Class IV; >50=Class V+
| Allergen / Parameter | Your Value | Unit | Normal / Class | Result |
|---|---|---|---|---|
| Total IgE | IU/mL | <100 (adult normal); <150 (atopic tendency) | ||
| Specific IgE: Dust Mite (D.pteronyssinus) | kUA/L | <0.35 (Class 0 = No allergy) | ||
| Specific IgE: House Dust | kUA/L | <0.35 | ||
| Specific IgE: Cat Dander | kUA/L | <0.35 | ||
| Specific IgE: Dog Dander | kUA/L | <0.35 | ||
| Specific IgE: Cockroach | kUA/L | <0.35 | ||
| Specific IgE: Pollen Mix (Grass) | kUA/L | <0.35 | ||
| Specific IgE: Mould (Alternaria) | kUA/L | <0.35 | ||
| Specific IgE: Cow's Milk | kUA/L | <0.35 | ||
| Specific IgE: Egg White | kUA/L | <0.35 | ||
| Specific IgE: Wheat | kUA/L | <0.35 | ||
| Specific IgE: Peanut | kUA/L | <0.35 | ||
| Specific IgE: Soybean | kUA/L | <0.35 | ||
| Specific IgE: Shrimp/Shellfish | kUA/L | <0.35 | ||
| Specific IgE: Latex | kUA/L | <0.35 | ||
| Eosinophil Count (Absolute) | cells/μL | <500 (mild if 500–1500; severe >1500) |